| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 2,166 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 1,500 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 750 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 192 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 1,834 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 7,959 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 1,040 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 5,891 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 858 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 3,234 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 215 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 4,974 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 275 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 3,090 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 920 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 419 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 713 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 1,578 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 696 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 6,702 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChiefDERIV | Jan 6 | D | 3,047 | — | — |
| Mersana Therapeutics, Inc. | MRSN | Timothy B. LowingerChief | Jan 6 | U | 10,466 | — | — |